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Purpose. 
The aim of this work was to evaluate the preparation process and in vitro release performances of HPMC coated systems for 
pulsatile release, containing verapamil as the active ingredient. Tableted cores of different size, formulated either for an 
immediate or prolonged drug liberation, were investigated in order to possibly meet diverse needs connected with the 
chronotherapy of ischemic heart disease, mainly occurring around awakening time. 
Methods. 
Tablets containing different amounts of verapamil hydrochloride were obtained by rotary press (AM8S, Ronchi, I) and coated 
with HPMC (Methocel®E50 8% w/v aqueous solutions) in a tangential-spray rotary fluid bed (GPCG 1.1 Glatt®, D) equipped 
with a Teflon-coated disk. Release tests (n=3) were performed in a three-position USP28 disintegration apparatus (DT3, 
Sotax, CH; 800 ml distilled water, 37.0±0.5°C). A single test unit was placed in each basket-rack assembly. Fluid samples 
were withdrawn automatically at fixed time points. Acetaminophen was quantified by spectrophotometer. 
Results. 
The selected operating conditions allowed a feasible, high-yield process to be performed on the tablets in exam. Moreover, 
thanks to the relative flexibility of the coating technique, only minor modifications were introduced when coating different 
size cores. The in vitro release tests carried out on immediate release tablets with increasing coat thickness showed a typical 
lag phase preceding the prompt release of verapamil. Delayed release performances dependent on the coating level were also 
exhibited by systems prepared starting from prolonged release cores. From such systems, as pursued, the drug was released 
slowly over an extended time period. For all system typologies, a linear relationship was found between lag time and the 
applied amount of coating polymer. 
Conclusion. 
The results obtained in terms of low-viscosity HPMC-based aqueous spray-coating feasibility and programmable delayed 
release behavior seem to point out a potential suitability of the system for evening-dosing chronotherapy of ischemic heart 
disease. 
